Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Federal Trade Commission
AstraZeneca
Cipla
Daiichi Sankyo
Baxter
Deloitte
McKinsey

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040859

« Back to Dashboard

NDA 040859 describes NOREPINEPHRINE BITARTRATE, which is a drug marketed by Baxter Hlthcare Corp, Metrics Pharm, Teva Pharms Usa, and West-ward Pharms Int, and is included in four NDAs. It is available from three suppliers. Additional details are available on the NOREPINEPHRINE BITARTRATE profile page.

The generic ingredient in NOREPINEPHRINE BITARTRATE is norepinephrine bitartrate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
Summary for 040859
Tradename:NOREPINEPHRINE BITARTRATE
Applicant:Baxter Hlthcare Corp
Ingredient:norepinephrine bitartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040859
Ingredient-typeCatecholamines
Medical Subject Heading (MeSH) Categories for 040859
Suppliers and Packaging for NDA: 040859
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040859 ANDA Baxter Healthcare Corporation 36000-162 N 36000-162-10
NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040859 ANDA Cardinal Health 55154-4450 N 55154-4450-8

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Mar 27, 2012TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Healthtrust
Queensland Health
Johnson and Johnson
Argus Health
Federal Trade Commission
Julphar
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.